Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChanBan: Varenicline and Bupropion for Nicotine Dependence
NCT00749658Phase 3Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, bupropion in nicotine dependence, sponsored by University of Minnesota. Started Nov 2008; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00749658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749658.